33rd Annual Meeting

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 tweeters

patent: 11 patents

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 70 Mendeley

Summary Twitter Patents Dimensions citations

So far, Dimensions has found 40 publications that cite this research output.

40

The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.

The prospect of targeting T cell immunoglobulin and mucin‐domain containing‐3 in renal cell carcinoma immunotherapy

Article in Scandinavian Journal of Immunology (June 2022)

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Article in Journal for ImmunoTherapy of Cancer (April 2022)

Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies

Article in Biological Chemistry (January 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.